Deployment and Upgrade for GMP-Compliant Pharmacovigilance

GMP-compliant pharmacovigilance data originates from quality management system records during drug manufacturing, clinical trial adverse event

Data Characteristics

GMP-compliant pharmacovigilance data originates from quality management system records during drug manufacturing, clinical trial adverse event reports, post-market adverse reaction monitoring data, and regulatory agency databases worldwide. Data updates are frequent, especially during new drug launches or when new safety signals emerge, typically daily or weekly. Documentation primarily consists of structured and semi-structured data, including Case Report Forms (CRFs), Adverse Drug Reaction (ADR) reports, product quality defect reports, and batch production records. Key fields include drug batch number, production date, expiration date, adverse event occurrence time, adverse event description, severity, outcome, related drug information (e.g., generic name, trade name, dosage form, strength, manufacturer), and patient demographics (age, gender, medical history). Units involve time (year, month, day, hour, minute), dosage (mg, g, ml), and frequency (times/day, times/week).

Constraints on Deployment and Upgrade

The multi-source nature and high update frequency of GMP-compliant pharmacovigilance data demand robust data integration capabilities and real-time or near real-time data synchronization mechanisms in the deployment solution. The coexistence of structured and semi-structured data places higher demands on the knowledge base's document parsing module, requiring effective handling of fixed fields and free-text descriptions. The need for massive storage and querying of historical data dictates storage system selection and indexing strategies. Free-text adverse event descriptions, with their variability and specialized terminology, require models with precise semantic understanding to avoid misjudgments or missed reports. Parameter configuration needs to balance data freshness with system resource consumption. During upgrades, new models or rules must undergo rigorous validation to ensure compliance and data accuracy, especially regarding confidence evaluation mechanisms for model outputs.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
UPLOAD_FILE_MAX_SIZE500 MBAccommodates large documents like batch production records and clinical reports.
maxContext3000 TokensBalances long adverse event descriptions with contextual relevance, improving semantic understanding accuracy.
PARSE_FILE_TIMEOUT_SECONDS300 secondsHandles parsing time for complex PDFs or scanned documents, preventing parsing interruptions.
Chunk size800–1000 charactersEnsures individual knowledge blocks contain sufficient information while avoiding information overload that impacts recall.
Recall countTop 8 entriesIncreases recall rate for relevant adverse event reports or regulatory clauses, covering more potential associations.
Similarity thresholdCalibrate based on actual measurementsBalances recall and accuracy based on the semantic similarity distribution of actual adverse event reports.

Common Pitfalls

  • New data is not effectively utilized by the model after a knowledge base update, leading to query results based on old information. This occurs when data synchronization or index rebuilding processes are incomplete, or caches are not refreshed in time.
  • The system fails to parse or incorrectly extracts fields when processing specific formats of regulatory agency reports. This happens when the document parser is not adapted for that specific format or its rules are outdated.
  • AI platform API calls return 401 Unauthorized errors. This indicates incorrect API Key configuration or insufficient permissions, such as using a general key to access resources requiring application-specific key permissions.

Verification Steps

  • Upload representative structured and semi-structured pharmacovigilance reports. Verify the knowledge base correctly parses files and extracts key fields, such as drug batch number and adverse event description.
  • For recent adverse event reports, use keywords or natural language queries to check if recalled knowledge items include the latest relevant information. Verify the number of recalled items meets expectations.
  • Simulate various complex query scenarios, such as queries involving multiple drugs or multiple adverse reactions. Evaluate the accuracy and completeness of model outputs. Determine an acceptable error rate threshold based on actual business needs.

The values provided are common starting points. Measure against specific samples to determine optimal configurations.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.